Category Archives: "Partners"

EMD Serono’s embracing carers launches ‘Time Counts’ to raise 1M minutes of support
Rockland, MA – EMD Serono, the biopharmaceutical company of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that [...]
CMSC opens weeklong mental health program to help mentor and train multiple sclerosis specialists
The Consortium of Multiple Sclerosis Centers (CMSC), working with the Foundation of the CMSC (FCMSC) and EMD Serono, launched a [...]
Alexion’s Soliris gets new, and lucrative, rare disease indication
June 28, 2019 (This news originally appeared in PharmaPhorum Website [...]
CMSC, multiple sclerosis non-profits and Polar Products recognizes over twenty years of progress
The quality of life benefits of cooling garments for people who suffer from heat intolerance is now recognized as never before thanks to [...]
Lenox Hill Hospital multiple sclerosis support group
Encouragement and Empowerment for People With MS. Living with MS has its challenges, but you don’t have to face them alone.  Lead [...]
Genentech presenting new Ocrevus (Ocrelizumab) data at AAN Meeting
Genentech to Present New OCREVUS (ocrelizumab) Data Analyses Showing Significant Reduction of Disability Progression in Relapsing and [...]
MSAA recognizes ten years of artwork from individuals with multiple sclerosis
CHERRY HILL, N.J., May 2, 2019 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to recognize ten years of [...]
OHSU doctors part of ‘breakthrough’ research on treating multiple sclerosis
PORTLAND, Ore. (KATU) – They're calling it a potential game-changer. Doctors at Oregon Health and Science University are part of a new [...]
Anne Cross, neurologist with pioneering work into B-cells/multiple sclerosis, awarded John Dystel Prize
This year’s John Dystel Prize for Multiple Sclerosis Research is being awarded to Anne H. Cross, a neurologist and MS chair in the [...]
Novartis gets FDA approval for Mayzent (Siponimod), the first oral drug to treat SPMS
EAST HANOVER, N.J., March 27, 2019 /PRNewswire/ --Novartis today announced that the US Food and Drug Administration (FDA) has approved [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM